Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Inflammatory Response to Endotoxin in Normal Adults
NCT02847247Phase 1Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Dec 2017
- Primary completion
- Aug 2019
- Modality
- Recombinant Proteins and Enzymes, Split/Subunit Vaccines, Therapeutic Vaccines
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Clinical Center Reference Endotoxin, sponsored by University of North Carolina at Chapel Hill. Primary endpoint: Change in peripheral blood absolute neutrophil count. Started Dec 2017; status: completed.
02
Drugs
Clinical Center Reference Endotoxin
Beyond the preview
Go deeper on NCT02847247.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02847247.